TM
TMO
Quarter ended Mar 29, 2025 · FY2025 Q1

Thermo Fisher Scientific (TMO) Revenue — Quarter Ended Mar 29, 2025

Revenue in the reported quarter declined from the immediately preceding quarter. Compared with the same quarter one year earlier, revenue was slightly higher.

Key takeaway

Quarter ended Mar 29, 2025 · FY2025 Q1

Revenue in the reported quarter declined from the immediately preceding quarter. Compared with the same quarter one year earlier, revenue was slightly higher.

Financial snapshot

Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.

Quarter revenue

$10.4B

Revenue reported for this quarter.

Quarter-over-quarter

-9.0%

Change from the immediately preceding quarter.

Year-over-year

+0.2%

Change from the comparable year-ago quarter.

Trailing four quarters

$42.9B

Sum of the latest four reported quarters.

Quarterly revenue trend

The latest four reported quarters with year-over-year comparisons.

Period endedRevenueYear-over-year change
Jun 29, 2024$10.5B-1.4%
Sep 28, 2024$10.6B+0.2%
Dec 31, 2024$11.4B+4.7%
Mar 29, 2025$10.4B+0.2%

Revenue performance

Revenue decreased from the prior quarter, reflecting a notable sequential decline. The year-over-year comparison showed a modest increase.

Quarterly comparison

The reported quarter's revenue was lower than the preceding quarter's level, which had been the highest among the recent four quarters. Revenue was slightly above the same quarter one year earlier.

What to watch

Monitor whether the sequential revenue decline continues or reverses in the coming quarters.